NEXT Biometrics Group ASA
ISIN
NO0010629108
Ticker
NEXT
Sector
Sub-Industry
Country
Norway
Year Founded
2000
ISIN
NO0010629108
Ticker
NEXT
Sector
Sub-Industry
Country
Norway
Year Founded
2000
Next Biometrics provides high-security fingerprint sensors with advanced technology. Thanks to our patented Active Thermal technology, we deliver large size sensors with slim form factors in a cost-effective way. It’s time to replace the password.
We founded Next Biometrics with the vision to provide the best biometric technology that protects data, information and people in a digital society. We went to market with our biometric fingerprint technology and one of our first major customers was Dell Computers.
Today we are serving and securing almost 10 million devices and customers around the world, including Fujitsu. We keep growing with new design wings, and have offices all around the world: Norway (HQ), US, India, Taiwan and China. We are a publicly traded company on the Oslo Stock exchange.
Worldwide
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 131,477,000.00 | 161,655,000.00 | 121,850,000.00 |
| Noncurrent Assets | N/A | 23,404,000.00 | 20,462,000.00 | 14,964,000.00 |
| Property Plant And Equipment | N/A | 17,197,000.00 | 16,504,000.00 | 12,347,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 5,446,000.00 | 3,926,000.00 | 2,579,000.00 |
| Deferred Tax Assets | N/A | 58,000.00 | 32,000.00 | 38,000.00 |
| Other Noncurrent Assets | N/A | 704,000.00 | 0.00 | N/A |
| Current Assets | N/A | 108,072,000.00 | 141,193,000.00 | 106,886,000.00 |
| Inventories | N/A | 21,725,000.00 | 18,987,000.00 | 22,935,000.00 |
| Current Trade Receivables | N/A | 4,056,000.00 | 11,801,000.00 | 6,261,000.00 |
| Cash and cash equivalents | 88,541,000.00 | 67,950,000.00 | 102,706,000.00 | 69,302,000.00 |
| Cash | N/A | N/A | 102,706,000.00 | 69,302,000.00 |
| Current Finance Lease Receivables | N/A | N/A | 517,000.00 | 0.00 |
| Other Current Assets | N/A | 14,342,000.00 | 7,181,000.00 | 8,387,000.00 |
| Equity And Liabilities | N/A | 131,477,000.00 | 161,655,000.00 | 121,850,000.00 |
| Equity | 134,801,000.00 | 97,188,000.00 | 134,253,000.00 | 96,000,000.00 |
| Issued Capital | N/A | 75,944,000.00 | 91,681,000.00 | 91,981,000.00 |
| Retained Earnings | N/A | -98,027,000.00 | -76,205,000.00 | -26,099,000.00 |
| Share Premium | N/A | 56,633,000.00 | 47,335,000.00 | 4,049,000.00 |
| Other Reserves | N/A | 62,637,000.00 | 71,442,000.00 | 26,069,000.00 |
| Noncurrent Liabilities | N/A | 6,908,000.00 | 2,027,000.00 | 1,279,000.00 |
| Deferred Tax Liabilities | N/A | 135,000.00 | 0.00 | N/A |
| Other Noncurrent Liabilities | N/A | 1,164,000.00 | 128,000.00 | 61,000.00 |
| Longterm Borrowings | N/A | 5,609,000.00 | 0.00 | N/A |
| Current Liabilities | N/A | 27,381,000.00 | 25,376,000.00 | 24,571,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 11,047,000.00 | 6,786,000.00 | 7,776,000.00 |
| Current Tax Liabilities Current | N/A | 60,000.00 | 317,000.00 | 143,000.00 |
| Other Current Liabilities | N/A | 13,928,000.00 | 15,676,000.00 | 14,904,000.00 |
| Line item in (nok) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 57,770,000.00 | 49,788,000.00 | 46,508,000.00 |
| Other Income | 363,000.00 | 967,000.00 | 1,784,000.00 |
| Employee Benefits Expense | 63,228,000.00 | 45,983,000.00 | 33,385,000.00 |
| Depreciation And Amortisation Expense | 15,279,000.00 | 7,069,000.00 | 7,229,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 6,577,000.00 | 0.00 | N/A |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 6,577,000.00 | 0.00 | N/A |
| Other Expense By Nature | 28,857,000.00 | 15,272,000.00 | 22,207,000.00 |
| Profit Loss From Operating Activities | -105,195,000.00 | -58,250,000.00 | -48,070,000.00 |
| Finance Income | 2,248,000.00 | 1,048,000.00 | 712,000.00 |
| Finance Costs | 811,000.00 | 1,299,000.00 | 118,000.00 |
| Profit Loss Before Tax | -104,784,000.00 | -58,394,000.00 | -46,394,000.00 |
| Income Tax Expense Continuing Operations | -2,990,000.00 | 1,621,000.00 | -60,000.00 |
| Profit (loss) | -101,794,000.00 | -60,014,000.00 | -46,333,000.00 |
| Profit Loss Attributable To Owners Of Parent | -101,794,000.00 | -60,014,000.00 | -46,333,000.00 |
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -101,794,000.00 | -60,014,000.00 | -46,333,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | 4,236,000.00 | 2,738,000.00 | -3,949,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | N/A | -740,000.00 | -4,261,000.00 | 990,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 15,279,000.00 | 7,069,000.00 | 7,229,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | 6,577,000.00 | 0.00 | N/A |
| Adjustments For Sharebased Payments | N/A | 4,376,000.00 | 8,805,000.00 | 4,733,000.00 |
| Other Inflows Outflows Of Cash Classified As Operating Activities | N/A | -5,748,000.00 | -8,738,000.00 | 2,130,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -80,369,000.00 | -47,681,000.00 | -32,378,000.00 |
| Cash Flows From Used In Investing Activities | N/A | 40,000.00 | 489,000.00 | 626,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 10,152,000.00 | 0.00 | N/A |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 0.00 | 626,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 4,574,000.00 | 2,787,000.00 | 2,738,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 61,297,000.00 | 83,268,000.00 | -2,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -19,032,000.00 | 36,076,000.00 | -33,751,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -1,559,000.00 | -1,320,000.00 | 347,000.00 |
| Cash and cash equivalents | 88,541,000.00 | 67,950,000.00 | 102,706,000.00 | 69,302,000.00 |
Please note that some sums might not add up.
NO0010629108
5967007LIEEXZXK9R405
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.